Linearity The linearity of the kit was assayed by testing samples spiked with appropriate concentration of GPX3 and their serial dilutions
Researchers should note that AOD 9604s pharmaceutical development was discontinued due to insufficient efficacy findings in clinical trials, which is relevant context when evaluating either compounds utility in a research setting.
Important Disclaimer: This peptide calculator is provided for research and educational purposes only and does not constitute medical advice, diagnosis, or treatment
This list is long but the NIH agrees some of these may be
10.1016/j.bbr.2020.112919 Summary Keywords retina, ischemia, BPC 157, L-NAME, rats Citation Zlatar M, Kokot A, Vuletic LB, Masnec S, Kralj T, Perisa MM, Barisic I, Radic B, Milanovic K, Drmic D, Seiwerth S and Sikiric P (2021) BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats